Where does Palvella Therapeutics's income statement data come from?

Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Net interest income	$2.59M+453%	$468K—	——	——
Research and development	$22.84M+180%	$8.15M—	——	——
General and administrative	$15.76M+165%	$5.94M—	——	——
Other operating expenses	$38.6M+174%	$14.1M—	——	——
Total operating expenses	$38.6M+174%	$14.1M—	——	——
Operating income	-$38.6M-174%	-$14.1M—	——	——
Other income (expense), net	——	$43K—	——	——
Income before income taxes	-$41.72M-139%	-$17.43M—	——	——
Income tax expense	$0—	$0—	——	——
Net income	-$41.72M-139%	-$17.43M-193%	$18.69M+156%	-$33.28M+27.2%
Diluted earnings per share	-$3.71+53.3%	-$7.95—	——	——
Basic earnings per share	-$3.71+53.3%	-$7.95—	——	——
Weighted-average shares, diluted	44.4M+489%	7.5M—	——	——
Weighted-average shares, basic	44.4M+489%	7.5M—	——	——
Fair Value Adjustments On Derivative Liabilities Contingent Value Right Liability	——	-$1.98M—	——	——
Interest Income Expense Nonoperating Royalty Agreement	-$5.82M-49.7%	-$3.89M—	——	——
Other Income Expense From Research And Development Tax Credit Receivable	$0-100%	$1.98M—	——	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	-$41.64M-139%	-$17.43M—	——	——
Interest Income (Expense), Operating	$2.59M+453%	$468K—	——	——
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax	——	$3K—	——	——
Other income, net (Note 6)	——	$43K—	——	——
Change in fair value of interest rate swap	-$394K+37.8%	-$633K—	——	——
EBIT	-$38.6M-174%	-$14.1M—	——	——
EBITDA	——	——	——	——
EBIT	-$38.6M-174%	-$14.1M—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

Where does Palvella Therapeutics's income statement data come from?: Every line is extracted from Palvella Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.